Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Emapalumab

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sobi Advances Gamifant In Interferon-Gamma-Driven Sepsis
    Sobi Advances Gamifant In Interferon-Gamma-Driven Sepsis

    07 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sobi-to-advance-gamifant-emapalumab-in-interferon-gamma-driven-sepsis-ids-based-on-embrace-topline-data-302655472.html

    PR NEWSWIRE
    07 Jan 2026
    Share Share
    Sobi Highlights Haematology Commitment At ASH 2025
    Sobi Highlights Haematology Commitment At ASH 2025

    05 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sobi-to-showcase-scientific-advances-and-commitment-to-haematology-at-ash-2025-302634280.html

    PR NEWSWIRE
    05 Dec 2025
    Share Share
    Sobi Showcases Commitment To Rare Inflammatory Care At ACR 2025
    Sobi Showcases Commitment To Rare Inflammatory Care At ACR 2025

    25 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/25/3174168/0/en/Data-presented-at-ACR-Convergence-2025-highlight-Sobi-s-commitment-to-advancing-care-across-rare-and-underserved-inflammatory-conditions.html

    GLOBENEWSWIRE
    25 Oct 2025
    Share Share
    Sobi Presents Latest Data On Rare Inflammatory Conditions At ACR
    Sobi Presents Latest Data On Rare Inflammatory Conditions At ACR

    24 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sobi-showcases-new-data-across-rare-inflammatory-conditions-at-acr-2025-302593848.html

    PR NEWSWIRE
    24 Oct 2025
    Share Share
    FDA Approves Gamifant for MAS in Still’s Disease Patients
    FDA Approves Gamifant for MAS in Still’s Disease Patients

    27 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/fda-approves-gamifant-emapalumab-lzsg-as-first-ever-treatment-for-adults-and-children-with-macrophage-activation-syndrome-in-stills-disease-302493712.html

    PR NEWSWIRE
    27 Jun 2025
    Share Share
    Novimmune’s Biologics Gamifant Receives Suppl Approval in US
    Novimmune’s Biologics Gamifant Receives Suppl Approval in US

    27 Jun 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761107

    FDA
    27 Jun 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.